[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363628-105":59,"doc-detail-363628-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","peroxisomal-lipid-metabolism-as-a-therapeutic-target-in-leukemia-review","Peroxisomal Lipid Metabolism as a Therapeutic Target in Leukemia - Review","","Lipid delivery and metabolism shape cancer cell fate, energy balance, redox control, and therapy resistance. Peroxisomes regulate fatty acid oxidation (FAO) and oxidative homeostasis in hematologic malignancies, with peroxisomal FAO selectively elevated in acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). Increased ACOX1, ABCD1/2, CROT, and PEX5 expression marks leukemia-specific vulnerabilities, where inhibition disrupts lipid homeostasis, causes very-long-chain fatty acid buildup, and promotes oxidative stress and lipotoxicity. Blocking peroxisomal FAO synergizes with venetoclax and cytarabine, while upstream PPAR regulation is implicated but incompletely defined.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/peroxisomal-lipid-metabolism-as-a-therapeutic-target-in-leukemia-review/363628/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/peroxisomal-lipid-metabolism-as-a-therapeutic-target-in-leukemia-review/363628.png","ImageObject",300,407,{"name":92,"@type":93},"Kurz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the central therapeutic idea behind targeting peroxisomal lipid metabolism in leukemia?","Question",{"text":113,"@type":114},"The review argues that peroxisomal FAO and related lipid-processing functions create metabolic vulnerabilities in leukemia cells. Disrupting peroxisome-mediated lipid delivery and oxidation can impair survival under metabolic and therapeutic stress.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does peroxisomal FAO differ between leukemia cells and normal cells?",{"text":118,"@type":114},"Peroxisomal FAO is reported as selectively elevated in AML and CLL. The associated increased expression of targets such as ACOX1, ABCD1/2, CROT, and PEX5 supports leukemia-specific vulnerability.",{"name":120,"@type":111,"acceptedAnswer":121},"Which effects result from pharmacologic or genetic inhibition of key peroxisomal pathways?",{"text":122,"@type":114},"Inhibition disrupts lipid homeostasis, induces very-long-chain fatty acid accumulation, and drives oxidative stress and lipotoxicity. The approach selectively kills leukemia cells while sparing normal progenitors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363628,1790195239,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Molecular Nutrition & Food Research  \nREVIEW   \nPeroxisomal Lipid Metabolism as a Therapeutic Target in Leukemia  \nEkaterina N. Parfenova  Paul A. Spagnuolo  \nDepartment of Food Science, University of Guelph, Guelph, Ontario, Canada Correspondence: Paul A. Spagnuolo ([paul.spagnuolo@uoguelph.ca](paul.spagnuolo@uoguelph.ca))  \nReceived: 31 January 2026  Revised: 10 April 2026  Accepted: 21 May 2026  \nKeywords: acute myeloid leukemia (AML) | chronic lymphocytic leukemia (CLL) | fatty acid oxidation (FAO) | lipid metabolism | peroxisomes  \nABSTRACT  \nLipid delivery and metabolism profoundly shape cancer cell fate, energy balance, redox control, and therapy resistance. Peroxisomes regulate fatty acid oxidation (FAO) and oxidative homeostasis with growing relevance in hematologic malignancies. Recent studies show peroxisomal FAO (pFAO) is selectively elevated in acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL), sustaining cancer cell survival under metabolic and therapeutic stress. Elevated ACOX1, ABCD1/2, CROT, and PEX5 expression underscores leukemia-specific peroxisomal vulnerability; their pharmacologic or genetic inhibition disrupts lipid homeostasis, induces very-long-chain fatty acid accumulation, and drives oxidative stress and lipotoxicity. This selectively kills leukemia cells while sparing normal progenitors. pFAO blockade synergizes with chemotherapy drugs such as venetoclax and cytarabine, enabling exploitation of metabolic vulnerabilities to improve therapeutic outcomes. Upstream, PPAR isoforms transcriptionally link lipid ligand sensing to peroxisomal gene expression, though their precise role in governing pFAO in leukemia remains undefined. Integrating solid tumor and leukemia insights, peroxisomes emerge as dynamic lipid-processing organelles coupling FAO, redox buffering, and inter-organelle exchange to cancer persistence. Targeting peroxisome-mediated lipid delivery offers a frontier for overcoming metabolic resilience and therapeutic resistance in leukemia.  \n1  Introduction  \nLipid metabolism is a critical regulator of cancer initiation and progression. Fatty acid oxidation (FAO) is upregulated across diverse malignancies, conferring chemotherapy resistance and enabling disease relapse. In normal cells, FAO catabolizes fatty acids to produce TCA-bound acetyl-CoA, fueling ATP production. In cancer cells, this pathway undergoes metabolic rewiring to support anabolic and cell growth activities. Thus, this FAO elevation in cancer relative to normal cells offers a therapeutic strategy to target fatty acid uptake and metabolism. Mitochondria and peroxisomes both execute FAO, with fatty acid chain length and saturation dictating the site of catabolism. While mitochondria have been the focus of drug-targeting efforts, inhibition of peroxisomal FAO (pFAO)  \nis emerging as a novel and promising anti-cancer approach [1–4] .  \nFatty acids fuel cancer cell proliferation and survival by generating ATP, NADH/FADH2 and NADPH, modulating cell signaling (e.g., via peroxisome proliferator-activated receptors (PPAR), CD36/FABP4), and promoting therapy resistance [5, 6] . They maintain membrane structures, serve as key energy substrates, support redox homeostasis under stress, and influence the bone marrow niche through adipocyte interactions and lipolysis [7, 8] . Peroxisomes function as metabolic hubs central to lipid processing, including β-oxidation of very-long-chain fatty acids (VLCFAs) and α-oxidation of branched-chain or polyunsaturated fatty acids, alongside ether phospholipid and bile acid synthesis. They also regulate reactive oxygen species (ROS) homeostasis via  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2026 The Author(s). Molecular Nutrition & Food Research ","cbCaiu3P20fi6sAb","https://ap.wps.com/l/cbCaiu3P20fi6sAb","pdf",1096698,"English","# Introduction\n## Cancer Metabolism: Fatty Acid Oxidation (FAO)","[{\"question\":\"What is the central therapeutic idea behind targeting peroxisomal lipid metabolism in leukemia?\",\"answer\":\"The review argues that peroxisomal FAO and related lipid-processing functions create metabolic vulnerabilities in leukemia cells. Disrupting peroxisome-mediated lipid delivery and oxidation can impair survival under metabolic and therapeutic stress.\"},{\"question\":\"How does peroxisomal FAO differ between leukemia cells and normal cells?\",\"answer\":\"Peroxisomal FAO is reported as selectively elevated in AML and CLL. The associated increased expression of targets such as ACOX1, ABCD1/2, CROT, and PEX5 supports leukemia-specific vulnerability.\"},{\"question\":\"Which effects result from pharmacologic or genetic inhibition of key peroxisomal pathways?\",\"answer\":\"Inhibition disrupts lipid homeostasis, induces very-long-chain fatty acid accumulation, and drives oxidative stress and lipotoxicity. The approach selectively kills leukemia cells while sparing normal progenitors.\"}]","Peroxisomal Lipid Metabolism as a Therapeutic Target in Leukemia - Review | PDF",1790152245,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c820fe8ea8cf7fb99c3449a7f321eb64.webp",983,1283,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a10884d504e9688f0ca8c168c798d6f1.webp",982,1281,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf44bb4e16968afb07127fc4bfb874b3.webp",981,1280,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76664011dd2da39287c91b0a5d7d562a.webp",980,1279]